The Egg Whisperer Show

ImputePGTA and PGT-P Explained: The Latest in Polygenic Embryo Testing with guest Jonathan Anomaly of Herasight

Nov 12, 2025
Jonathan Anomaly, former philosophy professor and Director of Communications at Herasight, dives into the intriguing world of polygenic embryo testing. He unpacks the groundbreaking ImputePGTA, revealing how it reconstructs embryo genomes to enhance traditional screening. The discussion touches on ethical concerns surrounding designer babies, the practical impacts for IVF patients, and the nuances of parental sequencing. Anomaly emphasizes the importance of informed consent and the necessity for transparency in this evolving field of reproductive technology.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

Polygenic Testing Reframes Embryo Screening

  • Polygenic PGT (PGTP) assesses hundreds or thousands of small variants rather than single-gene or chromosomal changes.
  • PGTP leverages large biobanks to create scores that estimate embryo genetic risk for complex traits and diseases.
ADVICE

Simulate Parental Genomes Before IVF

  • Sequence parents and simulate embryo outcomes to estimate expected genetic risks before IVF.
  • Use simulation results to decide whether another IVF round is likely to improve embryo genetic profiles.
INSIGHT

Reconstructing Embryo Genomes From Existing Data

  • HeraSight reconstructs embryo genomes by combining parental whole-genome sequences with standard PGT-A data.
  • This lets clinics run polygenic analyses without additional embryo biopsies or direct embryo sequencing.
Get the Snipd Podcast app to discover more snips from this episode
Get the app